Results 41 to 50 of about 8,357 (184)

Combined Transcatheter Tricuspid and Pulmonary Valve Replacement. [PDF]

, 2020
For patients with combined tricuspid and pulmonary valve disease, operative intervention carries high mortality risk. Published reports of combined transcatheter tricuspid and pulmonary valve replacement have been limited to single cases.A retrospective ...
Small, Adam J, Aksoy, Olcay, Salem, Morris M, Yang, Eric H, Levi, Daniel S, Aboulhosn, Jamil A   +5 more
core  

Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation

Frontiers in Cardiovascular Medicine, 2020
Tricuspid regurgitation (TR) has a not negligible prevalence and its severity is correlated with poorer outcomes. However, surgical options are rarely offered to these patients because of their high surgical risk.
Antonio Mangieri, Matteo Pagnesi, Damiano Regazzoli, Alessandra Laricchia, Edwin Ho, Ythan Goldberg, Mei Chau, Francesco Gallo, Andrea Fisicaro, Arif Khokhar, Antonio Colombo, Francesco Giannini, Azeem Latib   +12 more
doaj   +1 more source

State-of-the-Art Review: Anatomical and Imaging Considerations During Transcatheter Tricuspid Valve Repair Using an Annuloplasty Approach

Frontiers in Cardiovascular Medicine, 2021
Transcatheter techniques for the treatment of tricuspid regurgitation (TR) are being more frequently used and several new devices are in development.
Nina C. Wunderlich, Melanie Landendinger, Martin Arnold, Stephan Achenbach, Martin J. Swaans, Robert J. Siegel, Siew Yen Ho   +6 more
doaj   +1 more source

Current state of transcatheter tricuspid valve repair [PDF]

, 2020
Tricuspid regurgitation (TR) is a common valvular heart disease affecting >1.6 million people in the United States (US) and >70 million people worldwide.
Elmariah, Sammy, Kolte, Dhaval
core   +1 more source

Transcatheter Valve Replacement in Severe Tricuspid Regurgitation [PDF]

BACKGROUND: Severe tricuspid regurgitation is associated with disabling symptoms and an increased risk of death. Data regarding outcomes after percutaneous transcatheter tricuspid-valve replacement are needed.
Sharma, Rahul P, O\u27Neill, Brian P, Whisenant, Brian, Lim, D Scott, Hahn, Rebecca T, Mack, Michael J, Pislaru, Sorin, Smith, Robert, Sannino, Anna, Kodali, Susheel K, Garcia, Santiago, Lee, James, Thiele, Holger, Harb, Serge C, Thourani, Vinod H, Kipperman, Robert, Grayburn, Paul A, Eleid, Mackram, Kapadia, Samir, Fowler, Dale, Narang, Akhil, Szerlip, Molly, Lurz, Philipp, Makkar, Raj, Chadderdon, Scott, Yadav, Pradeep, Davidson, Charles J, Koulogiannis, Konstantinos, Haeffele, Christiane, Zahr, Firas, Sekaran, Nishant K, Leon, Martin B, Makar, Moody, Stewart-Dehner, Terri   +33 more
core   +2 more sources

Indications, limitations, and development of tricuspid valve interventions in adults

, 2022
Tricuspid regurgitation is associated with excessive mortality and poor outcomes regardless of the cause and associated comorbidities. Despite this clear association with mortality, tricuspid valve diseases remain undertreated.
Ibrahim, Reda, Kresoja, Karl-Patrik, Perrin, Nils, Lurz, Philipp, Modine, Thomas, Ruf, Tobias, Bouhout, Ismail, Fam, Neil, Ben Ali, Walid, Stephan von Bardeleben, Ralph   +9 more
core   +1 more source

Imaging Needs in Novel Transcatheter Tricuspid Valve Interventions

JACC: Cardiovascular Imaging, 2018
The advent of novel transcatheter therapies for severe tricuspid regurgitation (TR) has attracted much attention. Novel 3-dimensional imaging techniques have permitted analysis of the tricuspid valve (TV) anatomy from unparalleled views and better understanding of the underlying pathophysiology of TR.
Prihadi, E.A., Delgado, V., Hahn, R.T., Leipsic, J., Min, J.K., Bax, J.J.   +5 more
openaire   +3 more sources

Tratamiento endovascular de la válvula tricúspide: estado actual

Cirugía Cardiovascular, 2021
Resumen: De acuerdo con los últimos estudios, la tasa de intervención quirúrgica de la válvula tricúspide es muy baja, pese al gran número de pacientes con insuficiencia tricuspídea severa con indicación de cirugía, según las guías de práctica clínica ...
Gertrudis Parody-Cuerda, Emiliano Rodríguez-Caulo, José Miguel Barquero-Aroca   +2 more
doaj   +1 more source

Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR‐Specific Risk and Prevention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Aortic stenosis (AS) is associated with a heightened burden of cardiovascular comorbidities, atrial fibrillation (AF), and progressive valvular calcification, all of which may contribute to cerebrovascular events across the disease continuum.
Priyanka Boettger, Jamschid Sedighi, Martin Juenemann, Omar Alhaj‐Omar, Kerstin Piayda, Mani Arsalan, Samuel Sossalla, Won‐Keun Kim   +7 more
wiley   +1 more source

Nine‐Year Follow‐Up After M‐TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer, Thomas J. Stocker, Ludwig T. Weckbach, Julia Novotny, Philipp M. Doldi, Hannah Kempton, Steffen Massberg, Michael Näbauer, Jörg Hausleiter, Lukas Stolz   +9 more
wiley   +1 more source